|
2016
|
Geistlich Pharma India Pvt. Ltd., based in New Delhi, is a member of the Swiss parent company.
|
|
2014
|
Geistlich Pharma New Zealand and Australia Pty Ltd. have been established.
|
|
2012
|
The eighth affiliate Geistlich Pharma North America starts operations and is marketing biomaterials for bone regeneration in the USA and Canada.
|
|
2011
|
Geistlich Pharma expands its presence in Asia by setting up an affiliate in South Korea in addition to the affiliate set up in China in 2008.
|
|
2010
|
Geistlich Pharma sets up the affiliate Geistlich Pharma do Brasil based in Sao Paolo. In future Geistlich biomaterials will be available directly on the largest South American market.
|
|
2008
|
Foundation of the French affiliate Geistlich Pharma France SA. in Roissy-en-France near Paris. The Geistlich Pharma Representative office in Peking becomes the Chinese affiliate Geistlich Trading (Beijing) Co., Ltd.
|
|
2006
|
The industrial bone processing is discontinued.
|
|
2005
|
The Geistlich Pharma Representative Office is established in Peking with the objective to provide scientific support to the regenerative medicine and to further promote our technologies and products in China.
|
|
2003
|
The subsidiary Geistlich Biomaterials Italia is founded in Thiene, Italy.2002Production of gelatine is given up. The collagen foil activities are sold in 2005.
|
|
1999
|
The Geistlich company is converted into a holding company. The operational activities are assembled in newly formed subsidaries: Geistlich Pharma AG (biomaterials, pharmaceuticals), Geistlich Ligamenta AG (adhesives), Geistlich Alimenta AG (collagen foils), Geistlich Agrasana AG (fats and fertilizers), and Geistlich Immobilia AG (real estate).
|
|
1996
|
Foundation of the German subsidiary Geistlich Biomaterials Vertriebsgesellschaft mbH in Baden-Baden.
|
|
1995
|
The Geistlich company incorporates a quality system, that is certified according to ISO 9001:2000.Geistlich Pharma is additionally certified according to ISO 13485:2003, RL 93/42 EWG and CMDCAS and has implemented the requirements of 21 CFR Part 820.
|
|
1986
|
Geistlich Bio-Oss® is the first natural bone substitution material produced by the Biomaterials Division. Other biomaterials are realised outgoing by this innovation for the dental medicine and orthopedics.
|
|
1960
|
The subsidiary, Geistlich Sons Ltd. in Chester, Great Britain is founded. Since then, further collaborations have continued to be made throughout the world.
|
|
1951
|
Acquisition of the majority of the shares of Delta Zofingen AG
|
|
1950
|
GEWO GmbH subsidiary is founded in Baden-Baden, Germany.
|
|
1909
|
the sons of Eduard Geistlich transform the company into a shareholder company. The company developed further and took up production of pharmaceutical products in 1943.
|
